Elena Beltramo Selected Research

Elena Beltramo Research Topics

13	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2023 - 10/2006
7	Hypoxia (Hypoxemia) 12/2020 - 01/2013
4	Inflammation (Inflammations) 12/2023 - 11/2017
4	Diabetes Complications 11/2021 - 04/2006
3	Hyperglycemia 01/2022 - 01/2016
3	Thiamine Deficiency 11/2021 - 01/2020
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022 - 11/2021
2	Diabetic Angiopathies (Diabetic Angiopathy) 11/2021 - 09/2008
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021 - 04/2021
2	Hypertension (High Blood Pressure) 01/2013 - 10/2006
1	Blindness (Hysterical Blindness) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020

16	Retinaldehyde (Retinal)IBA 12/2023 - 10/2006
12	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 04/2006
8	Thiamine (Aneurin)FDA Link 12/2023 - 04/2006
3	benphothiamine (benfotiamine)IBA 01/2022 - 09/2008
3	VitaminsIBA 11/2021 - 09/2008
2	TransketolaseIBA 04/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2018
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2017 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2010
1	Thioctic Acid (Lipoic Acid)IBA 01/2022
1	Sp1 Transcription FactorIBA 04/2021
1	Fenofibrate (CiL)FDA LinkGeneric 12/2020
1	Neuroprotective AgentsIBA 12/2016
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 12/2016
1	Caspase 8 (Caspase-8)IBA 01/2016
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2014
1	Advanced Glycation End ProductsIBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 06/2010
1	polyolIBA 04/2006

3	Therapeutics 05/2023 - 01/2020
1	Surgical Amputation (Amputations) 01/2022
1	Intravitreal Injections 12/2020
1	Lasers (Laser) 12/2020
1	Light Coagulation 12/2020